Phase II study of gemcitabine/vinorelbine (GV) as first or second line chemotherapy in patients with metastatic soft tissue sarcoma (STS).

被引：0
|
作者：
Morgan, JA [1 ]
George, S [1 ]
Desai, J [1 ]
Amand, MS [1 ]
Horton, D [1 ]
Wilkins, E [1 ]
Manola, J [1 ]
Demetri, GD [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9009
引用
收藏
页码：820S / 820S
页数：1
相关论文
共 50 条
  • [1] Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcoma
    Von Burton, G
    Rankin, C
    Zalupski, MM
    Mills, GM
    Borden, EC
    Karen, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (01): : 59 - 61
  • [2] Docetaxel (taxotere) as first line therapy for metastatic or recurrent soft tissue sarcoma (STS): A phase II trial
    Blackstein, ME
    Eisenhauer, EA
    Bramwell, V
    Belanger, K
    Verma, S
    Beare, S
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 848 - 848
  • [3] Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
    Donadio, M
    Ardine, M
    Berruti, A
    Ritorto, G
    Fea, E
    Mistrangelo, M
    Coccorullo, Z
    Bergnolo, P
    Comandone, A
    Bertetto, O
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (02) : 147 - 152
  • [4] Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
    Michela Donadio
    Mara Ardine
    Alfredo Berruti
    Giuliana Ritorto
    Elena Fea
    Marinella Mistrangelo
    Zaira Coccorullo
    Paola Bergnolo
    Alessandro Comandone
    Oscar Bertetto
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 147 - 152
  • [5] A Phase II Study of Gemcitabine, Vincristine, and Cisplatin As Second-Line Treatment for Patients With Advanced Soft Tissue Sarcoma
    Luo, Zhiguo
    Zhang, Xiaowei
    Peng, Wei
    Wu, Xianghua
    Wang, Huijie
    Yu, Hui
    Wang, Jialei
    Chang, Jianhua
    Hong, Xiaonan
    MEDICINE, 2015, 94 (43)
  • [6] A phase II trial of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer
    Meshref, M. M.
    Samir, S.
    Saad, E.
    Gouda, Y.
    Elmesidy, S.
    Koheil, H.
    Elzawahri, H.
    Kandil, A.
    Abdelhamid, T.
    Zaki, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An EORTC Soft Tissue and Bone Sarcoma Group randomized phase II study.
    Gelderblom, H.
    Blay, J.
    Seddon, B. M.
    Leahy, M.
    Ray-Coquard, I. L.
    De Brauwer, A.
    Veyt, E.
    Weitman, S. D.
    Hogendoorn, P. C.
    Hohenberger, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study
    Merimsky, O
    Meller, I
    Flusser, G
    Kollender, Y
    Issakov, J
    Weil-Ben-Arush, M
    Fenig, E
    Neuman, G
    Sapir, D
    Ariad, S
    Inbar, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 45 (02) : 177 - 181
  • [9] Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study
    Ofer Merimsky
    Isaac Meller
    Gidon Flusser
    Yehuda Kollender
    Josephine Issakov
    Miriam Weil-Ben-Arush
    Eyal Fenig
    Gad Neuman
    Dov Sapir
    Shmuel Ariad
    Moshe Inbar
    Cancer Chemotherapy and Pharmacology, 2000, 45 : 177 - 181
  • [10] A phase I-II study of gemcitabine and vinorelbine as second line treatment of patients with metastatic breast cancer.
    Fanelli, M
    Morabito, A
    Filipelli, G
    Vitale, S
    Palmeri, S
    De Bella, MT
    Gilberti, S
    Ferraù, F
    Massida, B
    Cascinu, S
    Catalano, V
    Gasparini, G
    ANNALS OF ONCOLOGY, 2000, 11 : 35 - 35
12345